GRIFOLS reported EUR4.3B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alcon AG USD 37.06B 5.98B Mar/2026
Almirall EUR 2.76B 472.53M Dec/2025
Amarin USD 290M 51M Dec/2025
argenx SE USD 57.63B 13.25B Jun/2026
AstraZeneca USD 178.16B 111.83B Aug/2026
Bayer EUR 49.51B 10.82B Aug/2026
Cie Automotive EUR 3.56B 640.97M Dec/2025
Demant DKK 46.01B 10.48B Dec/2025
Ence Energia y Celulosa EUR 555.23M 37.3M Mar/2026
Essilor EUR 76.16B 48.88B Jun/2026
Ferrovial EUR 42.03B 969.86M Aug/2026
Fresenius EUR 26.24B 3.72B Aug/2026
Fresenius Medical Care EUR 11.32B 642.58M Mar/2026
Genmab DKK 20.48B 1.02B Dec/2025
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
GRIFOLS EUR 4.25B 1.16B Aug/2026
Hikma Pharmaceutical USD 3.49B 1.14B Aug/2026
Inditex EUR 157.64B 13.78B Mar/2026
Lakefront Biotherapeutics EUR 1.73B 119.93M Mar/2026
Merck EUR 46.78B 6.52B Mar/2026
Novartis USD 240.59B 67.17B Jun/2026
Philips EUR 23.09B 615.44M Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Smith & Nephew USD 3.54B 9.16B Aug/2026
UCB EUR 46.41B 13.94B Dec/2025
Viscofan EUR 2.69B 112.9M Jun/2026